Abdurrahman Yurtaslan Ankara Onkoloji Eğitim ve Araştırma Hastanesi, Ortopedi ve Travmatoloji Kliniği, 06200 Yenimahalle, Ankara, Türkiye.
Jt Dis Relat Surg. 2022;33(2):419-425. doi: 10.52312/jdrs.2022.624. Epub 2022 Jul 6.
In this study, we present the characterization of tumors located in the fibula, which is a rare site for tumors, and the clinical and functional results of patients with fibular tumors that we operated in our clinic.
Between February 2008 and December 2018, a total of 104 patients (58 males, 46 females; mean age: 26±18 years; range, 3 to 78 years) who were operated for tumor located in the fibula were retrospectively analyzed. Demographic data, histopathological diagnosis, tumor localization, surgical method and postoperative complications, metastases, follow-up time, and functional results of the patients were recorded. The fibula was divided into three groups as proximal, diaphysis and distal one-third.
The mean follow-up was 56±25.3 (range, 24 to 108) months. Eighty (76.9%), seven (6.7%) and 17 (16.3%) patients were located proximal, diaphysis and distal to the fibula, respectively. The number of patients with malignant tumors located in the fibula was 26 (25%), the tumor was benign in 54 (51.9%) patients and 24 (23%) tumors were borderline. The most common tumor localized to the fibula was osteochondroma with 28 (26.9%) patients. The most common malignant tumors located in the fibula were Ewing sarcoma and osteosarcoma in 11 patients each. The most common surgical method was curettage in 44 (42.3%) patients. Distant organ metastases were present in 18 (17.3%) patients. The Musculoskeletal Tumor Society score of 17 patients who underwent resection of the proximal fibula were 87%.
Fibula is a rare location for tumors and fibula tumors tend to be located more proximal. Tumors located in the fibula have good functional outcomes after surgery.
本研究旨在对位于腓骨的肿瘤进行特征描述，腓骨是肿瘤的罕见发病部位，并报告在我院接受治疗的腓骨肿瘤患者的临床和功能结果。
2008 年 2 月至 2018 年 12 月，回顾性分析了 104 例（58 例男性，46 例女性；平均年龄：26±18 岁；范围：3 至 78 岁）因腓骨肿瘤而接受手术的患者。记录患者的人口统计学数据、组织病理学诊断、肿瘤定位、手术方法和术后并发症、转移、随访时间以及患者的功能结果。将腓骨分为近侧、骨干和远 1/3 三部分。
平均随访时间为 56±25.3 个月（范围：24 至 108 个月）。80 例（76.9%）、7 例（6.7%）和 17 例（16.3%）患者的肿瘤分别位于腓骨的近侧、骨干和远 1/3 。26 例（25%）患者的腓骨肿瘤为恶性，54 例（51.9%）患者的肿瘤为良性，24 例（23%）患者的肿瘤为交界性。最常见的位于腓骨的肿瘤是骨软骨瘤，有 28 例（26.9%）患者。最常见的位于腓骨的恶性肿瘤是尤文肉瘤和骨肉瘤，各有 11 例患者。44 例（42.3%）患者采用刮除术。18 例（17.3%）患者发生远处器官转移。17 例接受近端腓骨切除的患者的肌肉骨骼肿瘤协会评分（Musculoskeletal Tumor Society score）为 87%。
腓骨是肿瘤的罕见发病部位，腓骨肿瘤更倾向于位于近侧。腓骨肿瘤手术后功能结果良好。
